付表ⅠE 指定を受けた医薬品の有効成分(4回目の見直しによる追加)
号(Sub-heading) 品 名 Description 2842.90 フェルマガート fermagate 2843.90 パデリポルフィン padeliporfin 2844.40 ヨードフィルト酸(123Ⅰ) iodofiltic acid (123I)
Download 付表ⅠE 指定を受けた医薬品の有効成分(4回目の見直しによる追加)
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
The following cargo information ... - 税関 Japan …
www.customs.go.jpThe following cargo information shall be filed under the Advance Filing Rules on Maritime Container Cargo Information. Appendix 3 Data Elements to Be Filed (1)
Information, Maritime, Graco, Container, On maritime container cargo information
AEO program - 税関 Japan Customs
www.customs.go.jpAEO program (Authorized Economic Operator) Customs & Tariff Bureau Ministry of Finance, Japan
Customs Form C No.5360-B CUSTOMS DECLARATION
www.customs.go.jp(-A-) Japan Customs Customs Form C No.5360-B Flight No./Name of Vessel ( CUSTOMS DECLARATION Declaration of Personal Effects and Unaccompanied Articles Please fill in the following information and submit to Customs.
Declaration, Japan, Custom, Customs declaration, Japan customs customs, Customs declaration declaration
タイ協定原産地証明書の記入要領 原産地証明書は …
www.customs.go.jp財務省関税局業務課 1. Goods consigned from (Exporter’s business name, address, country) Reference No. CERTIFICATE OF ORIGIN (Combined declaration and certificate)
2.運送要件証明書について - customs.go.jp
www.customs.go.jp説明事項 1.原産地証明書の記載事項及び審査 2.運送要件証明書について 3.税関における手続き 41
Rules of Origin under Japan’s EPAs - 税関 Japan …
www.customs.go.jpRules of Origin under Japan’s EPAs Requests concerning translation, reproduction and adaptation should be addressed to Customs and Tariff Bureau, Ministry of …
Rules, Under, Japan, Custom, Origin, Rules of origin under japan s epas, Epas
EPA 原産地規則マニュアル - customs.go.jp
www.customs.go.jpepa 原産地規則マニュアル 平成30年6月 東京税関業務部総括原産地調査官 関税局業務課監修
加硫したゴムの分析 - customs.go.jp
www.customs.go.jp関税中央分析所報 第46号 71 3.2 ラマン分光法 分以降には、 加硫前後を比較したSBR のラマンスペクトルをFig.4 に示す。
特定輸出者一覧 (Authorized Exporter) - customs.go.jp
www.customs.go.jpクボタマシナリートレーディング株式会社 KUBOTA Machinery Trading Co.,Ltd. 4120001037991 クラリオン株式会社 Clarion Co.,Ltd. 6030001017472
付表ⅠA 指定を受けた医薬品の有効成分
www.customs.go.jp号(Sub-heading) 品名 Description 2818.30 アルゲルドラート algeldrate 2833.22 アルスルフ alusulf 2842.10 アルマシラート almasilate
Related documents
Harzardous Drug Medication List *COLOR CODE AND PPE KEY
aspiruslibrary.orgCepastat lozenge N/ABlack EPA Cerubidine N/ABlack EPA Cetacaine aerosol N/ABlack Trash EPA Cetrorelix Blue Trash Yellow NIOSH Chloral hydrate syrup N/ABlack EPA Chlorambucil tablet Black Yellow NIOSH Chloramphenicol Blue Trash Yellow NIOSH Chorhexidine gluconate solution N/ABlack Trash EPA Choriogonadotropin Blue Trash Yellow NIOSH Cidofovir Blue Trash Yellow NIOSH ...
Drug, Lists, Medication, Harzardous, Harzardous drug medication list
MEDICATION GUIDE - media.celgene.com
media.celgene.comMEDICATION GUIDE POMALYST® (POM-uh-list) (pomalidomide) capsules What is the most important information I should know about POMALYST? Before you begin taking POMALYST, you must read and agree to all of the instructions in the POMALYST REMS®
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
media.celgene.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use POMALYSTsafely and effectively. See full prescribing information for
OUR CLINICAL TRIALS - Amgen Oncology
www.amgenoncology.comInformation as of 4/1/2016. Statements are based on the company’s current beliefs and Amgen disclaims any duty to update. For more information about Amgen and its business, including risks and uncertainties, please refer to Amgen’s filings with the SEC.
OUR CLINICAL TRIALS - Amgen Oncology
www.amgenoncology.com*For more detailed information about the trial, visit www.clinicaltrials.gov or www.amgentrials.com. †The regulatory approval pathway for biosimilars requires study of a single indication and permits extrapolation to other reference indications with scientific justification.
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBCCA HD List . abiraterone1 enzalutamide1 PACLitaxel1 acitretin3 epirubicin1 PACLitaxel, nab4 AFAtinib1 eriBULin1 palbociclib4 alectinib4 erlotinib1 pamidronate3 amsacrine1 estramustine1 PAZOPanib1 anastrozole1 etoposide1 pemetrexed1 arsenic trioxide 1 everolimus1 PERTuzumab1 atezolizumab4 exemestane1 plerixafor3 avelumab4 pomalidomide1 aXitinib1 PONATtinib1 azaCITIDine1 fludarabine1 procarbazine1
Dexamethasone 4 mg tablets - Medicines
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Dexamethasone 4 mg tablets Dexamethasone Read all of this leaflet carefully before you start taking this medicine because it contains important